Aromasin 25 mg

AROMASIN 25 MG tablets contain exemestane, an aromatase inhibitor used to manage certain conditions in postmenopausal women. This medication is commonly prescribed for hormone receptor-positive breast cancer. AROMASIN 25 MG is manufactured by Pfizer Canada ULC.

AROMASIN 25 MG is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the amount of estrogen produced by the body, which can help slow or stop the growth of certain types of breast cancer cells. This medication is often used as part of a broader treatment plan, including surgery, radiation, or other therapies.

Common effects of AROMASIN 25 MG may include hot flashes, joint pain, fatigue, and nausea. Some users may also experience headaches, insomnia, or mild digestive issues. These effects vary among individuals and are not experienced by everyone taking the medication.

AROMASIN 25 MG should be handled with care, especially by those with a history of osteoporosis or liver disease. It is important to follow the advice of a healthcare provider regarding its use. Pregnant women or those planning to become pregnant should avoid this medication due to potential risks.

AROMASIN 25 MG may interact with other medications, including certain types of hormonal therapies and drugs that affect liver enzymes. It is advisable to inform a healthcare provider about all current medications before starting AROMASIN 25 MG. Alcohol consumption should be moderated while taking this medication.